Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

In this week’s edition of the biotech bi-weekly, learn more about CRAIC technologies’ 5D Spectral Surface Mapping solution, ...

The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.

Labroots’ virtual events are designed to spark impactful scientific discussions while connecting with individuals worldwide ...

The company’s focus will be on progressing the clinical validation of its idiopathic pulmonary fibrosis treatment.

AI-powered tools like Merck’s Aiddison can accelerate drug identification and optimise design, cutting both costs and time to ...

Molecular Devices' CellXpress AI streamlines cell culture processes, reducing human error and improving efficiency in drug ...

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

In essence, the future of AI is inextricably linked to advancements in data management, making it an indispensable enabler of ...